Doctor profile · Federal record
Dr. Steven Vernali, MD
Dermatology Physician (CMS: Dermatology) · Student in an Organized Health Care Education/Training Program · Wilmington, NC
- NPI 1720584824
- Accepts Medicare
- MIPS 90.0 / 100 · 2023
- 8 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6781 Parker Farm Dr Ste 300
Wilmington, NC 284053161
(910) 763-1555 - Mailing address
-
20 Calle Hermosa
Pensacola Beach, FL 325612421
Credentials & registration
- NPI registered
- April 2018 — 8 yrs on file
- Profile last updated
- July 4, 2022
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- North Carolina #2022-01789
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720584824. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,651
Distinct HCPCS
10
Medicare allowed
$163,201
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 839 | 146 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 405 | 305 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 246 | 198 | $46 | |
11102 |
Biopsy of related skin growth, first growth | 233 | 203 | $87 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 221 | 221 | $105 | |
17110 |
Destruction of skin growth, 1-14 growths | 141 | 127 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 133 | 98 | $121 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 85 | 19 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 83 | 63 | $47 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 62 | 62 | $156 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 269. This provider delivers 9.9× the peer median.Open Payments
Industry payments received
All-time total
$771
Transactions
30
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $295.31 | |
| ABBVIE INC. | 12 | $187.77 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $120.73 | |
| Incyte Corporation | 2 | $46.02 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $23.67 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18.81 | |
| GENZYME CORPORATION | 1 | $17.69 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17.58 | |
| LEO Pharma Inc. | 1 | $15.34 | |
| Amgen Inc. | 1 | $15.03 | |
| Arcutis Biotherapeutics, Inc. | 1 | $13.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
555
Patients
316
Total drug cost
$63,636
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 101 | 71 | $1,325 |
| Clobetasol Propionate | Generic | 94 | 64 | $6,764 |
| Mupirocin | Generic | 48 | 28 | $477 |
| Ketoconazole | Generic | 47 | 33 | $905 |
| Fluorouracil | Generic | 41 | 34 | $4,102 |
| Hydrocortisone | Generic | 41 | 34 | $284 |
| Doxycycline Hyclate | Generic | 40 | 18 | $2,534 |
| Prednisone | Generic | 28 | 19 | $132 |
| Nystatin | Generic | 27 | 0 | $205 |
| Clindamycin Phosphate | Generic | 23 | 15 | $1,470 |
Hospital affiliations
Frequently asked questions
What is Dr. Steven Vernali's medical specialty?
Dr. Steven Vernali practices Dermatology Physician in Wilmington, NC.
Where does Dr. Steven Vernali practice?
Dr. Steven Vernali practices at 6781 Parker Farm Dr Ste 300, Wilmington, NC 284053161. Office phone: 9107631555.
What is Dr. Steven Vernali's NPI?
Dr. Steven Vernali's National Provider Identifier (NPI) is 1720584824, issued by NPPES.
Does Dr. Steven Vernali accept Medicare assignment?
Yes. Dr. Steven Vernali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Vernali commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.